Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 1 39-1, 1999, Pages

  Suzuki, Hidekazu ^a   Seto, Koichi ^a   Shinoda, Yuichi ^a   Mori, Mikiji ^a   Ishimura, Yuzuru ^a   Suematsu, Makoto ^a   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotide; Flt 1; Kinase insert domain containing receptor; Reverse transcription polymerase chain reaction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OXYGEN; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; PARACRINE SIGNALING; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; UMBILICAL VEIN;

EID: 0032953872     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.1.g92     Document Type: Article

References (10)

1. Ferrara, N., K. A. Houck, L. B. Jakeman, J. Winer, and D. W. Leung. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47: 211-218, 1991.
2. Houck, K. A., N. Ferrara, J. Winer, G. Cachianes, B. Li, and D. W. Leung. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5: 1806-1814, 1991.
3. Ingber, D., T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, and J. Folkman. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348: 555-557, 1990.
4. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52: 2745-2756, 1973.
5. Mise, M., S. Arii, H. Higashituji, M. Furutani, M. Niwano, T. Harada, S. Ishigami, Y. Toda, H. Nakayama, M. Fukumoto, J. Fujita, and M. Imamura. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23: 455-464, 1996.
6. Namiki, A., E. Brogi, M. Kearney, E. A. Kim, T. Wu, T. Couffinhal, L. Varticovski, and J. M. Isner. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270: 31189-31195, 1995.
7. Nomura, M., S. Yamagishi, S. Harada, Y. Hayashi, T. Yamashima, J. Yamashita, and H. Yamamoto. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270: 28316-28324, 1995.
8. Plate, K., G. Breier, H. A. Weich, and W. Risau. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
9. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
10. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324: 1-8, 1991.